Bioceres Crop Solutions Corp.

BIOX · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Revenue$333,300$464,829$419,446$328,456
% Growth-28.3%10.8%27.7%
Cost of Goods Sold$203,100$283,240$239,198$202,019
Gross Profit$130,200$181,589$180,249$126,437
% Margin39.1%39.1%43%38.5%
R&D Expenses$0$17,183$15,345$6,947
G&A Expenses$72,469$77,450$70,226$42,990
SG&A Expenses$88,345$94,267$85,541$57,359
Sales & Mktg Exp.$15,876$16,817$15,315$14,369
Other Operating Expenses$45,555$25,318$10,874$20,599
Operating Expenses$133,900$136,768$111,760$84,905
Operating Income-$3,700$44,821$54,184$39,870
% Margin-1.1%9.6%12.9%12.1%
Other Income/Exp. Net-$50,200-$34,785-$35,078-$25,806
Pre-Tax Income-$53,900$10,035$19,106$14,064
Tax Expense$1,300$3,779-$1,069$17,973
Net Income-$51,800$3,243$18,780-$7,200
% Margin-15.5%0.7%4.5%-2.2%
EPS-0.820.0520.3-0.17
% Growth-1,689.1%-82.8%276.5%
EPS Diluted-0.820.0510.3-0.17
Weighted Avg Shares Out63,20062,84062,14642,302
Weighted Avg Shares Out Dil63,20063,48563,18642,302
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$50,100$26,872$23,788$17,926
Depreciation & Amortization$17,392$21,295$19,391$9,188
EBITDA$13,592$55,455$72,376$47,913
% Margin4.1%11.9%17.3%14.6%